Agenus (AGEN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical Agenus (AGEN)

Previous 10

To: Kirk © who wrote (142)	5/8/2024 12:43:23 AM
From: Area51	of 146

True. I think not a great deal for AGEN. One take I saw was that AGEN sold $400 million in future cash flows for $75 million. For a company with a marketcap of 250 million that is a pretty significant hit. And still they don't have near enough money to get them to cash flow breakeven right? Disappointing that that was the best they could do for raising some capital. Wainright analyst maintained a $40 price target after the deal, but Wainright is not that reliable in their price targets in my experience.

Agenus (AGEN) \| Stock Discussion ForumsShare	RecommendKeepReply Mark as Last Read Read Replies (2)

To: Area51 who wrote (143)	5/8/2024 9:51:32 AM
From: Kirk ©	1 Recommendation of 146

You have to hope the Ligand sharks bring more to the table than just cash. Mr. Wonderful and Mark Cuban have made it clear on that show they do not work for free. The positive is Agenus didn't dilute shareholders with the deal and I believe the leaders are still taking stock for much of their pay. The big question is can they hold most of these recent gains off the lows and use the former green resistance line as support? .

Agenus (AGEN) \| Stock Discussion ForumsShare	RecommendKeepReply Mark as Last Read

To: Area51 who wrote (143)	5/14/2024 1:49:45 PM
From: Kirk ©	of 146

Have you read the MiNK Earnings transcript? Phrases like "compelling data demonstrating 215's ability to eradicate tumors" and "The signals that we observed that we published in Nature Communications showed the true pronounced benefit that we believe these cells can bring to patients that showed rapid excavation, clearance of virus, prevention of secondary infections and we saw survival rates that exceeded 75% in a population of patients that historically saw a mortality rate that exceeded about 65%." Seem stunning yet the stock hasn't moved much. seekingalpha.com

Agenus (AGEN) \| Stock Discussion ForumsShare	RecommendKeepReply Mark as Last Read

From: Kirk ©	7/18/2024 9:17:52 AM
	of 146

AGEN: -63% \| Agenus(AGEN) shares are trading lower after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.

Agenus (AGEN) \| Stock Discussion ForumsShare	RecommendKeepReply Mark as Last Read